bromopyruvate has been researched along with Glioma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, J; Dong, X; Jiang, Q; Li, H; Liu, J; Liu, L; Sheng, Y; Wang, H; Wang, L; Yang, X | 1 |
| Huang, Y; Peng, Y; Sun, G; Sun, X; Tang, X; Zhang, N; Zhang, S; Zhao, L; Zhong, R | 1 |
| Dringen, R; Ehrke, E; Rastedt, W; Stapelfeldt, K; Steinmeier, J | 1 |
| Cao, YG; Liu, P; Sun, SJ; Tan, XY; Wu, T; Xu, DQ; Zhang, BW | 1 |
| Abou El-Magd, RM; Chung, SP; El Sayed, SM; Fukui, K; Kagami, S; Sakai, T; Shishido, Y; Watanabe, H | 1 |
| Chung, SP; Diem, TH; El Sayed, SM; El-Magd, RM; Fukui, K; Kagami, S; Sakai, T; Shishido, Y; Watanabe, H | 1 |
6 other study(ies) available for bromopyruvate and Glioma
| Article | Year |
|---|---|
3-Bromopyruvate inhibits the malignant phenotype of malignantly transformed macrophages and dendritic cells induced by glioma stem cells in the glioma microenvironment via miR-449a/MCT1.
Topics: Cell Transformation, Neoplastic; Cells, Cultured; Dendritic Cells; Glioma; Lactic Acid; Macrophages; MicroRNAs; Monocarboxylic Acid Transporters; Neoplastic Stem Cells; Pyruvates; Symporters; Tumor Microenvironment | 2020 |
Glycolytic inhibition by 3-bromopyruvate increases the cytotoxic effects of chloroethylnitrosoureas to human glioma cells and the DNA interstrand cross-links formation.
Topics: Adenosine Triphosphate; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cell Line, Tumor; DNA Damage; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance; Glioma; Glutathione; Glycolysis; Humans; O(6)-Methylguanine-DNA Methyltransferase; Pyruvates; Tumor Suppressor Proteins | 2020 |
Menadione-mediated WST1 reduction assay for the determination of metabolic activity of cultured neural cells.
Topics: Animals; Astrocytes; Cell Survival; Cells, Cultured; Formazans; Glioma; Humans; Methylphenazonium Methosulfate; Neurons; Octoxynol; Oxidation-Reduction; Pyruvates; Rats; Rats, Wistar; Spectrophotometry; Vitamin K 3 | 2017 |
3-Bromopyruvate inhibits cell proliferation and induces apoptosis in CD133+ population in human glioma.
Topics: AC133 Antigen; Apoptosis; bcl-2-Associated X Protein; Brain Neoplasms; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Glioma; Humans; Pyruvates | 2016 |
D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvate.
Topics: Adenosine Triphosphate; Animals; Cell Line, Tumor; D-Amino-Acid Oxidase; Disease Models, Animal; Enzyme Inhibitors; Female; Genetic Therapy; Glioblastoma; Glioma; Glycolysis; Humans; Hydrogen Peroxide; Mice; Neoplastic Stem Cells; Oxidative Stress; Pyruvates; Rats; Rats, Sprague-Dawley; Transfection | 2012 |
3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Cell Survival; Citric Acid; D-Amino-Acid Oxidase; Electrophoresis, Polyacrylamide Gel; Glioblastoma; Glioma; Glycolysis; Humans; Hydrogen Peroxide; Immunoblotting; Lactic Acid; Oxidative Stress; Pyruvates; Pyruvic Acid; Tetrazolium Salts; Thiazoles | 2012 |